Inhibition of fibrillin 1 expression using U1 snRNA as a vehicle for the presentation of antisense targeting sequence.

This study examines whether the mimicking of selected properties of naturally occurring antisense RNAs in prokaryotes allows efficient inhibition of gene expression by in situ-expressed recombinant molecules in mammalian cells. Prokaryotic regulatory transcripts are expressed at high levels and have hairpin structures at their termini, features reminiscent of small nuclear RNAs (snRNAs) which are abundant and stable in the nucleus of all mammalian cells. A sequence complementary to fibrillin-1 (FBN1) mRNA, interrupted in its center by a hammerhead ribozyme, was substituted for the Sm protein binding site between the stem-loop structures of U1 snRNA. Expression of the chimeric antisense RNA resulted in dramatic inhibition of expression of fibrillin-1 message and protein in stably transfected cultured cells. The inhibitory effect was localized to the nucleus. The biological properties of U1 snRNA may provide a widely applicable vehicle for the in vivo delivery of antisense targeting sequences.

[1]  I. Bozzoni,et al.  U1 small nuclear RNA chimeric ribozymes with substrate specificity for the Rev pre-mRNA of human immunodeficiency virus. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  C. Stein,et al.  Does antisense exist? , 1995, Nature Medicine.

[3]  H. Dietz,et al.  Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. , 1995, Human molecular genetics.

[4]  W. Boelens,et al.  Nuclear retention of RNA as a mechanism for localization. , 1995, RNA: A publication of the RNA Society.

[5]  J. Rossi,et al.  Ribozymes expressed within the loop of a natural antisense RNA form functional transcription terminators. , 1995, Gene.

[6]  E. Wagner,et al.  Bulged-out nucleotides protect an antisense RNA from RNase III cleavage. , 1995, Nucleic acids research.

[7]  H. Dietz,et al.  Expression of a mutant human fibrillin allele upon a normal human or murine genetic background recapitulates a Marfan cellular phenotype. , 1995, The Journal of clinical investigation.

[8]  R. Riek,et al.  Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA. , 1994, Biochemistry.

[9]  G. Carmichael,et al.  Targeted nuclear antisense RNA mimics natural antisense-induced degradation of polyoma virus early RNA. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Pictet,et al.  Can hammerhead ribozymes be efficient tools to inactivate gene function? , 1994, Nucleic acids research.

[11]  T. Cech,et al.  Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA. , 1993, Science.

[12]  L. Neckers,et al.  Antisense technology: biological utility and practical considerations. , 1993, The American journal of physiology.

[13]  P. Hendry,et al.  A ribozyme with DNA in the hybridising arms displays enhanced cleavage ability. , 1992, Nucleic Acids Research.

[14]  Ada Hamosh,et al.  Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene , 1991, Nature.

[15]  R. Lührmann,et al.  Diversity in the signals required for nuclear accumulation of U snRNPs and variety in the pathways of nuclear transport , 1991, The Journal of cell biology.

[16]  R. Pepperkok,et al.  Mammalian nuclei contain foci which are highly enriched in components of the pre‐mRNA splicing machinery. , 1991, The EMBO journal.

[17]  E. Darżynkiewicz,et al.  The trimethylguanosine cap structure of U1 snRNA is a component of a bipartite nuclear targeting signal , 1990, Cell.

[18]  C. Guthrie,et al.  Unexpected flexibility in an evolutionarily conserved protein‐RNA interaction: genetic analysis of the Sm binding site. , 1990, The EMBO journal.

[19]  R. Simons,et al.  The unusual stability of the IS10 anti‐sense RNA is critical for its function and is determined by the structure of its stem‐domain. , 1989, The EMBO journal.

[20]  M. Cornelissen.  Nuclear and cytoplasmic sites for anti-sense control. , 1989, Nucleic acids research.

[21]  R. Simons,et al.  Naturally occurring antisense RNA control--a brief review. , 1988, Gene.

[22]  W. Gerlach,et al.  Simple RNA enzymes with new and highly specific endoribonuclease activities , 1988, Nature.

[23]  E. Engvall,et al.  Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils , 1986, The Journal of cell biology.

[24]  M. Inouye,et al.  Engineering of the mRNA-interfering complementary RNA immune system against viral infection. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Weiner,et al.  A compensatory base change in U1 snRNA suppresses a 5′ splice site mutation , 1986, Cell.

[26]  H. Weintraub,et al.  Inhibition of thymidine kinase gene expression by anti-sense RNA: A molecular approach to genetic analysis , 1984, Cell.

[27]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[28]  H. Boedtker,et al.  RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. , 1977, Biochemistry.

[29]  R. Simons,et al.  Antisense RNA control in bacteria, phages, and plasmids. , 1994, Annual review of microbiology.

[30]  J. Nickoloff,et al.  Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. , 1992, Analytical biochemistry.

[31]  C. Guthrie,et al.  Spliceosomal snRNAs. , 1988, Annual review of genetics.

[32]  T. Cech,et al.  Biological catalysis by RNA. , 1986, Annual review of biochemistry.